Assessing the benefit-risk balance of drugs. Some lessons from the COVID pandemic-Reference-Cited by-同舟云学术

Assessing the benefit-risk balance of drugs. Some lessons from the COVID pandemic

Published:2024-06-19 Issue:8 Volume:23 Page:959-967
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Cracowski Jean-Luc¹^ORCID,Molimard Mathieu²^ORCID,Richard Vincent³^ORCID,Roustit Matthieu⁴^ORCID,Khouri Charles¹⁴^ORCID

Affiliation:

1. Centre Régional de Pharmacovigilance de Grenoble, Université Grenoble Alpes, Inserm U1300, Grenoble, France

2. Service de Pharmacologie, Université Bordeaux, Bordeaux, France

3. Service de Pharmacologie, Université Rouen, Rouen, France

4. Centre d’Investigation Clinique de Grenoble, Université Grenoble Alpes, Inserm U1300, Grenoble, France

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2024.2368811

Reference59 articles.

1. Application of unsupervised machine learning to identify and characterise hydroxychloroquine misinformation on Twitter

2. Managing the COVID-19 infodemic: promoting healthy behaviours and mitigating the harm from misinformation and disinformation [Internet]. [cited 2024 Jun 1]. Available from: https://www.who.int/news/item/23-09-2020-managing-the-covid-19-infodemic-promoting-healthy-behaviours-and-mitigating-the-harm-from-misinformation-and-disinformation

3. Framework for Managing the COVID-19 Infodemic: Methods and Results of an Online, Crowdsourced WHO Technical Consultation

4. Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs

5. Efficacy and Effectiveness Too Trials: Clinical Trial Designs to Generate Evidence on Efficacy and on Effectiveness in Wide Practice